No description available.

La recherche des marqueurs biologiques de la tendreté a fait l’objet de nombreux travaux chez les animaux producteurs de viande et en particulier les bovins. A l’issue de ces études, une expression différentielle de la protéine Hsp27 entre des groupes de tendreté extrême a été mise en évidence. Cette protéine est présente à un « carrefour » biologique de l’interactome lié à la tendreté. Comprendre les mécanismes d’action de la protéine Hsp27 dans la tendreté de la viande bovine est l'un des défis de recherche dans le domaine de la production de viande. Dans cette optique, mon travail de thèse (2010-2013) avait pour objectif d’analyser le rôle de Hsp27 dans le développement du muscle et son implication dans le déterminisme des caractéristiques des tissus liés à la qualité de la viande. La première étape de ce travail a consisté à produire un modèle de souris présentant une inactivation du gène de la protéine Hsp27 (KO HspB1) et d’analyser leur phénotype comparativement à des témoins. Les souris KO HspB1 sont viables, fertiles et ne présentent aucune anomalie majeure, mais ont un format plus petit que celui de leurs témoins. L’analyse de leurs caractéristiques musculaires par une technique immunohistoligique mise au point spécifiquement (Publication 1) n’a pas révélé de différences. Au niveau ultrastructural, l'observation du muscle des souris par microscopie électronique à transmission a révélé des différences ultrastructurales entre les deux génotypes à T0 post-mortem avec des écarts entre les myofibrilles très espacées chez les souris KO HspB1 et un appareil contractile musculaire moins organisé. Ces différences sont encore plus marquées à T72 heures post-mortem. Ainsi le phénotype musculaire fin des souris KO HspB1 est plus altéré (Publication 2). Une analyse bio-informatique a été réalisée dans l'objectif de compléter la liste des interacteurs de la protéine Hsp27 et des gènes cibles de l’invalidation d’HspB1 susceptibles de participer à des différences de structure du muscle et de la tendreté. Les partenaires ou cibles prédits de Hsp27 sont des protéines impliquées dans différentes fonctions, comme des Heat shock proteines, des régulateurs de l'apoptose, des facteurs de traduction, des protéines du cytosquelette et des antioxydants. Les abondances de 15 protéines ont été quantifiées par Western-bloting dans deux muscles (m. Soleus, m. Tibialis). Elles sont modifiées chez les souris dépourvues de Hsp27 principalement dans le muscle le plus oxydatif. Cette étude démontre l'existence de liens fonctionnels entre Hsp27 et ses cibles prédites qui pourraient participer au phénotype fin des souris (Publication 3). Pour compléter cette étude, une analyse protéomique du muscle Tibialis anterior a été menée en utilisant la technique d’électrophorèse bidimensionnelle couplée à la spectrométrie de masse. La comparaison des protéomes spécifiques de ces deux génotypes a permis de mettre en évidence des profils d’expression différents pour plusieurs protéines. Elle confirme l’effet muscle spécifique du KO et révèle un lien avec le métabolisme du calcium et des Hsps différentes de celles mises en évidence dans le muscle oxydatif (Publication 4). L'ensemble des données issues de cette étude réalisée dans une espèce modèle apporte des connaissances nouvelles susceptibles d’éclairer sur les mécanismes moléculaires impliqués dans l’établissement de la tendreté de la viande bovine. Elle suggère que le statut en Hsp, les processus apoptotiques et la protection contre le stress oxydatif contribuent à l'évolution de l'ultrastructure post-mortem des muscles et à la tendreté de la viande. Ces nouvelles connaissances seront validées ultérieurement sur muscle bovin. / Thanks to genomics, we have previously identified markers of beef tenderness, and computed a bioinformatic analysis that enabled us to build an interactome in which we found Hsp27 at a crucial node. Understanding the role of Hsp27 in the development of muscle and in the determinism of beef tenderness is one of the research challenges in meat production. In this context, my pHDthesis (2010-2013) aimed to analyze the role of Hsp27 in muscle development and its involvement in the determination of the characteristics related to the quality of the meat tissue. In this study, we generated mice devoid of Hsp27 protein by homologous recombination of the HspB1 gene as an animal model. The HspB1-/ - mice were viable and fertile, showing no apparent abnormality but a smaller than their control format. The muscle structure of animals was examined by optical microscopy and transmission electron microscopy. The first approach, made by a developed immunohistochemical classification (Publication 1), did not reveal any differences in the characteristics of muscle fibers (contractile and metabolic type, shape, perimeter, cross-sectional area) but a trend for a higher proportion of small fibers. Different myosin heavy chains electrophoretic profiles were also observed in HspB1-/- mice. At the ultrastructural level, examination of the myofibrillar material showed destructured myofibrils and higher gaps between myofibrils in HspB1-/-, and a greater disintegration of myofibrils at 72h postmortem (Publication 2). We have used a network-based approach for understanding the contribution of Hsp27 to tenderness through the prediction of its interactors related to tenderness. We have revealed the direct interactors of Hsp27. The predicted partners of Hsp27 included proteins involved in different functions e.g. members of Hsp families, regulators of apoptosis, translation factors, cytoskeletal proteins and antioxidants. The abundances of 15 proteins were quantified by Western blotting in two muscles of HspB1-null mice and their controls. We observed changes in the amount of most of the Hsp27 predicted targets in mice devoid of Hsp27 mainly in the most oxidative muscle (Soleus. Our study demonstrates the functional links between Hsp27 and its predicted targets. It suggests that Hsp status, apoptotic processes and protection against oxidative stress are crucial for post-mortem muscle metabolism, subsequent proteolysis, and therefore for beef tenderness (Publication 3). To complete this study, we performed a proteomic analysis of m. Tibialis anterior (glycolytic muscle), using 2D gel electrophoresis, to detect changes in protein abundance subsequent to the invalidation of HspB1 gene. This study confirms the muscle specific effect of HspB1 invalidation and reveals a new list of Heat shock proteins different from those highlighted in oxidative muscle and relationships with calcium (Publication 4). All together, these results provided from a model species showed the very important role of Hsp27 for muscle ultrastructure and revealed its implication in different muscle biological pathways. This provided new elements for understanding the crucial role for Hsp27 in the modulation of the tenderizing process of muscle during meat ageing that will be further examined in beef.

<p>Huntington’s disease (HD) is an autosomal dominant neurodegenerative disorder caused by a polyglutamine expansion in the huntingtin protein. Recent research demonstrates that post-translational modifications of huntingtin could be an important determinant of mutant huntingtin’s toxicity in HD. In particular, phosphorylation at residues serine 13 and 16 within the first 17 amino acids of huntingtin (N17), have been shown to be critical modulators of mutant huntingtin’s toxicity and localization, and can be triggered by stress. This project aims to study how phosphorylation within N17 alters the interactome at this site and what physiological stress results in the nuclear localization of N17 and huntingtin. The initial search to identify potential interactors was conducted through an affinity chromatography assay using a wild type striatal cell line derived from knock in mouse model of HD. Fluorescent lifetime imaging microscopy (FLIM) to determine Fӧrester resonance energy transfer (FRET), co-immunoprecipitation and co-immunofluorescence assays were then used to validate real interactors of N17. Analysis from this project has validated two previously unidentified interactors of N17; SET, a small nucleo-oncoprotein, and vimentin, a type 3 intermediate filament. Both interactors have suggested two potentially novel roles for N17 within huntingtin, in cell cycle regulation and intermediate filament dynamics. Finally, smart screening techniques using stress-inducing compounds reveal that the sensitivity of N17 to stress and its subsequent nuclear localization can be attributed in part to activation of oxidative stress pathways. Data shown here can be expanded upon to elucidate how huntingtin function and response to cell stress are regulated and mediated via N17 and potentially how this mechanism is disrupted within HD.</p> / Master of Science (MSc)

The mechanical strength of plant tissues and organs can be attributed to specific properties of the cell wall. In many cases, in order to establish their final shape, cells deposit various cell wall materials in a localized manner. This is achieved by highly organized action of the endomembrane system which is essential for biosynthesis and secretion of cell wall proteins and polysaccharides. The exocyst complex is a conserved tethering complex in eukaryotes and it is involved in tethering of secretory vesicles to the sites of secretion at the plasma membrane. In this study, we address several aspects of the plant exocyst complex architecture and cell wall development using molecular biology techniques and advanced confocal microscopy. We demonstrated that two SEC10 exocyst subunits are present in Arabidopsis thaliana and share redundant functions. We also showed that the architecture of the plant exocyst complex shares several structural features with the yeast one. We demonstrated the importance of the functional EXO84b exocyst subunit for normal tracheary element development and showed that the main constituents of the secondary cell walls are deposited normally in exocyst mutants. We described a clear difference in the exocyst microtubule-independent dynamics in epidermal cells vs. cell type...

Arabidopsis thaliana trichomes are large unicellular epidermal outgrowths with a specific development and intriguing shape, which makes them an excellent cell type for our research of cell polarization mecha- nisms. Cell polarity is essential for plant development and the exocyst complex is one of its key regulators. It is an octameric protein complex that mediates polarized exocytosis and growth by targeted tethering of secretory vesicles to the plasma membrane. Its EXO70 subunit functions as a landmark for exocytosis site and physically binds the target membrane through interaction with phospholipids. A remarkable multipli- cation of EXO70 subunit paralogs in land plant genomes is well documented, but the functional diversity of these paralogs remains to be described. In trichomes we revealed the specific role of the EXO70H4 paralog in secondary cell wall deposi- tion, especially in callose synthase delivery. We documented formation of a thick secondary cell wall during the maturation phase of wild type trichome development and a lack of it in the exo70H4 mutant. Moreover, we showed evidence for silica deposition dependency on callose synthesis. Further, we unveiled the formation of apical and basal plasma membrane domains, which differ in their phospholipid compo- sition and ability to bind...

Parkin is a cytosolic E3 ubiquitin ligase that is recruited to the mitochondria during cellular stress and has been suggested to be involved in a variety of biological processes such as mitophagy. The recruitment of Parkin (PARK2) to the mitochondria is dependent upon the kinase activity and the accumulation of PINK1 on damaged mitochondria. Mutations in either PINK1 or Parkin genes disrupt this protective pathway and lead to the accumulation of damaged mitochondria. From a clinical standpoint, mutations in the PARK2 gene have been associated with the progression and onset of autosomal recessive juvenile parkinsonism. Without the presence of a quality control system such as that of the PINK1/Parkin pathway, the accumulation of damaged mitochondria could lead to increased levels of oxidative stress, a decrease in ATP, and the progression towards cellular death. However, many of the details regarding the mechanism of Parkin-mediated ubiquitination and its involvement in mitophagy are not fully established. The intent of this thesis is to further explore the function of Parkin by utilizing the yeast-two hybrid system to identify novel Parkin interactors/substrates. A HeLa (cervical cell carcinoma) cDNA library was screened using Parkin124-465 as the "bait" protein. From this screening, six positive Parkin interactors were isolated and characterized. Using this approach it is possible to gain a better understanding of the function of Parkin in regulating cellular processes such as mitophagy.

Le protéasome est une protéase multimérique essentielle et hautement conservée au cours de l’évolution. Le protéasome 26S eucaryote est l’unité catalytique du système Ubiquitine-Protéasome et contrôle de ce fait de nombreux processus cellulaires. Son dysfonctionnement participe à la pathogenèse de nombreuses maladies. Le protéasome émerge notamment comme une cible thérapeutique de choix dans le traitement de cancers. Il semble donc important d’identifier l’ensemble des processus cellulaires dans lesquels le protéasome est impliqué ainsi que l’ensemble de ses régulateurs.Mon travail de thèse a consisté à identifier et caractériser de nouveaux partenaires physiques et fonctionnels du protéasome par une approche multi-technique. Nous étudions ces facteurs dans l’organisme modèle S. cerevisiae et déterminons s’ils sont fonctionnellement conservés dans les cellules de Mammifères.Après avoir identifié des partenaires physiques et fonctionnels au moyen de cribles à grande échelle, j’ai analysé les données et établi une bibliothèque pondérée de ces partenaires. J’ai ainsi mis en évidence de nouveaux acteurs potentiellement impliqués dans le fonctionnement du protéasome. De plus, j’ai caractérisé les protéines Spg5p et Poc5p. Mes données suggèrent que Spg5p participe à la régulation du protéasome en quiescence. Poc5p, présente à la fois chez l’Homme et la levure, participe à la régulation du protéasome à au moins deux niveaux différents : elle joue un rôle de point de contrôle dans l’assemblage du complexe et un rôle inhibiteur sur son activité. / The proteasome is a highly conserved essential proteolytic machine. The eukaryotic 26S proteasome is the hydrolytic heart of the ubiquitin-mediated degradation pathway and therefore controls many cellular pathways. Its dysfunction is involved in the pathogenesis of numerous diseases. Notably, the proteasome has emerged as an interesting drug target for anti-cancer therapy. It seems therefore important to identify all cellular processes in which the proteasome is involved and all of its regulators.My work was to identify and characterize new physical and functional partners of the proteasome by a multi-technical approach. We characterize these factors in the model organism S. cerevisiae and determine if they are functionally conserved in mammalian cells.After identifying physical and functional partners through large-scale screens, I analyzed the data and developed a weighted library of these partners. I have thus highlighted new actors potentially involved in the proteasome functioning. In addition, I characterized the Spg5p and Poc5p proteins. My data suggest that Spg5p participates in the regulation of proteasome during quiescence. Poc5p, presents both in human and yeast, is involved in the regulation of proteasome at at least two different levels: it acts as a checkpoint in the complex assembly and have an inhibitory effect on its activity.

Alle Organismen sind für ihr Überleben auf Metalle angewiesen. Hierbei gibt es für jedes Metall einen Konzentrationsbereich, der das Optimum zwischen Metallmangel, -bedarf und -toxizität darstellt. Es gilt mittlerweile als erwiesen, dass alle Organismen zur Aufrechterhaltung des Metallgleichgewichts ein komplexes Netzwerk von Proteinen und niedermolekularen Verbindungen entwickelt haben. Die molekularen Komponenten dieses Netzwerks sind nur zu einem Teil bekannt und charakterisiert: In den letzten Jahren wurden einige Proteinfamilien identifiziert, deren Mitglieder Metalle durch Lipidmembranen transportieren. Eine dieser Metalltransporterfamilien ist die Cation Diffusion Facilitator (CDF)-Familie: Alle charakterisierten Mitglieder exportieren Metalle aus dem Zytoplasma – entweder in zelluläre Kompartimente oder aus der Zelle heraus. Von den zwölf Mitgliedern dieser Familie in Arabidopsis thaliana (A. thaliana) – Metall Toleranz Protein (MTP)-1 bis -12 – wurden bisher AtMTP1 und AtMTP3 charakterisiert. In dieser Arbeit wird die Charakterisierung von AtMTP2 beschrieben. Wie die homologen Proteine AtMTP1 und AtMTP3 führt AtMTP2 zu Zn-Toleranz, wenn es heterolog in Zn-sensitiven Hefemutanten exprimiert wird. Mit AtMTP2 transformierte Hefemutanten zeigten darüber hinaus erhöhte Co-Toleranz. Expression von chimären AtMTP2/GFP Fusionsproteinen in Hefe, A.thaliana protoplasten und in stabil transformierten A.thalinana Planzenlinien deutet auf Lokalisation of AtMTP2 in Membranen des Endoplasmatischen Retikulums (ER) hin, wenn GFP an den C-Terminus von MTP2 fusioniert wird. Fusion of GFP an den N-Terminus von AtMTP2 führte zu Lokalisation in der vakuolären Membran, was wahrscheinlichsten auf Fehllokalisierung durch Maskierung eines ER-Retentionsmotivs (XXRR) am N-Terminus von AtMTP2 zurückgeht. Dies legt nahe, dass AtMTP2 die erwähnten Metalle in das Endomembransystem der Zelle transportieren kann. Eine gewebespezifische Lokalisierung wurde mit Pflanzen durchgeführt, die das β-Glucuronidase (GUS)-Reporterprotein bzw. chimäre Fusionsproteine aus EGFP und AtMTP2 unter Kontrolle des nativen pMTP2-Promotors exprimierten. Diese Experimente bestätigten zum einen, dass der pMTP2-Promotor nur unter Zn-Defizienz aktiv ist. GUS-Aktivität wurde unter diesen Bedingungen in zwei Zonen der Wurzelspitze beobachtet: in den isodiametrischen Zellen der meristematischen Zone und in der beginnenden Wurzelhaarzone. Darüber hinaus konnte gezeigt werden, dass die EGFP-Fusionsproteine unter Kontrolle des nativen pMTP2-Promotors nur in epidermalen Zellen exprimiert werden. Für eine homozygote Knockout- Linie, mtp2-S3, konnte bisher kein eindeutiger Phänotyp identifiziert werden. Auf Grundlage der bisher durchgeführten Charakterisierung von AtMTP2 erscheinen zwei Modelle der Funktion von AtMTP2 in der Pflanze möglich: AtMTP2 könnte essentiell für die Versorgung des ER mit Zn unter Zn-Mangelbedingungen sein. Hierfür spricht, dass AtMTP2 in jungen, teilungsaktiven und damit Zn-benötigenden Wurzelzonen exprimiert wird. Die auf die Epidermis beschränkte Lokalisation könnte bei diesem Modell auf die Möglichkeit der zwischenzellulären Zn-Verteilung innerhalb des ER über Desmotubules hindeuten. Alternativ könnte AtMTP2 eine Funktion bei der Detoxifizierung von Zn unter Zn-Schock Bedingungen haben: Es ist bekannt, dass unter Zn- Mangelbedingungen die Expression der zellulären Zn-Aufnahmesysteme hochreguliert wird. Wenn nun die Zn-Verfügbarkeit im Boden z. B durch eine pH-Änderung innerhalb kurzer Zeit stark ansteigt, besteht die Notwendigkeit der Entgiftung von Zn innerhalb der Zelle, bis der starke Einstrom von Zn ins Zytoplasma durch die Deaktivierung der Zn-Aufnahmesysteme und einer geringeren Expression in der Pflanze gedrosselt ist. Ein ähnlicher Mechanismus wurde in der Bäckerhefe S. cerevisae beschrieben, in der darüber hinaus ein Zn-Transporter verstärkt exprimiert wird, der Zn durch Transport in die Vakuole entgiften kann. Es ist durchaus möglich, dass in Arabidopsis AtMTP2 die Zn-Detoxifizierung unter diesen speziellen Bedingungen durch Zn-Transport in das ER oder die Vakuole vermittelt. Zur Identifikation weiterer Komponenten des Metallhomöostasenetzwerks sind verschiedene Ansätze denkbar. In dieser Arbeit wurde in Hefe ein heterologer Screen durchgeführt, um Interaktoren für vier Mitglieder der Arabidopsis-CDF-Familie zu identifizieren. Unter den 11 im Hefesystem bestätigten Kandidaten befindet sich mit AtSPL1 ein AtMTP1-Interaktionskandidat, der möglicherweise eine Rolle bei der Cu-,Zn-Homöostase spielt. Als wahrscheinliche AtMTP3-Interaktionskandidaten wurde die c”-Untereinheit der vakuolären H+-ATPase AtVHA identifiziert sowie mit AtNPSN13 ein Protein, das vermutlich eine Rolle bei Fusionen von Vesikeln mit Zielmembranen spielt. Ein anderer Ansatz zur Identifikation neuer Metallhomöostasegene ist die vergleichende Elementanalyse von natürlichen oder mutagenisierten Pflanzenpopulationen. Voraussetzung für diesen Ansatz ist die schnelle und genaue Analyse des Elementgehalts von Pflanzen. Eine etablierte Methode zur simultanen Bestimmung von bis zu 65 Elementen in einer Probe ist die Inductively Coupled Plasma Optical Emission Spectrometry (ICP OES). Der limitierende Faktor für einen hohen Probendurchsatz ist die Notwendigkeit, Proben für die Analyse zu verflüssigen. Eine alternative Methode der Probenzuführung zum Analysegerät ist die elektrothermale Verdampfung (ETV) der Probe. Zur weitgehend automatisierten Analyse von Pflanzenmaterial mit minimiertem Arbeitsaufwand wurde eine Methode entwickelt, die auf der Kopplung der ETV mit der ICP OES basiert. / All organisms require for their survival essential metals. For each required metal exists an optimal concentration between metal deficiency and -toxicity. It has become evident that all organisms developed a complex network of proteins and low molecular compounds to maintain the equilibrium between all metals. Only few molecular components of this metal-homeostasis network are characterized in detail: A number of protein families whose members transport metals over the barrier of lipid-membranes have been identified during the last couple of years. One of those metal-transport families is the Cation Diffusion Facilitator (CDF) family. All characterized members export metals from the cytoplasm – either into cellular compartments or outside the cell. From the 12 Arabidopsis thaliana (A.thaliana) members – Metal Tolerance Protein (MTP)-1 to 1-2 – only MTP1 and MTP3 have been characterized yet. In this work, characterization of MTP2 is described. As was found for the homologous proteins AtMTP1 and AtMTP3, heterologous expression of AtMTP2 in Zn-sensitive yeast mutants leads to enhanced Zn-tolerance. Less pronounced, enhanced tolerance was also found for Co when AtMTP2 was expressed in Co sensitive yeast mutants. Expression of chimeric AtMTP2/GFP fusion proteins in yeast, A.thaliana protoplasts and in stably transformed A.thalinana plant lines indicated localization of MTP2 in membranes of the endoplasmic reticulum, when GFP was fused to the C-terminal end of MTP2. Fusion of GFP to the N-terminal end of MTP2 lead to vacuolar localization that is most likely explained as mistargeting due to masking of an ER retrieval motive (XXRR) found at the N-terminus of MTP2. This suggests that AtMTP2 mediates the transport of Zn and Co into the endomembrane system of the cell. Tissue specific localization was performed with plant lines expressing the β-Glucuronidase (GUS) reporter protein and with plant lines expressing chimeric fusions of GFP with AtMTP2 under control of the native pMTP2 promoter. Those experiments confirmed Affymetrix Genechip® data suggesting activity of the pMTP2 promoter only under Zn-deficiency. GUS activity was only found under Zn-deficiency in two zone of root tips – the meristematic zone, characterized by isodiamtric cells, and in the beginning differentiation zone, characterized by appearing root hairs. Confocal microscopy with plant lines expressing chimeric MTP2 /GFP fusions demonstrated that expression of AtMTP2 is restricted to epidermal cells. A phenotype for the homozygous mtp2-S3 knockout mutant could not be identified yet. Based on the data obtained as yet / two mode of action of AtMTP2 in planta seam likely: AtMTP2 could be essential for delivery of Zn to the ER under Zn-deficiency. This is supported by the fact, that AtMTP2 is active in young, dividing (and therefore Zn-requiring) zones of the root. The epidermal-restricted expression of AtMTP2 points towards a distribution of Zn in these root zones of Zn within desmotubules. Alternatively, AtMTP2 could have a Zn-detoxifying function under Zn-shock. It is known that in yeast under Zn-deficiency not only the expression of an Zn-uptake transporter is up-regulated, but also the expression of a vacuolar Zn-transporter. It mediates Zn-detoxification of surplus Zn that enters cells upon Zn-resupply before shut down of the Zn uptake system. AtMTP2 could exert this function when soil Zn-availability raises suddenly, for example due to rain after a drought. Different means/methods are perceivable to identify further components of the metal homeostasis network. In this work, a heterologuos screen was performed in yeast to identify interacting proteins for four members of the Arabidopsis CDF-family. Among 11 candidates identified and confirmed in the Split Ubiquitin System (SUS, a Yeast-2-Hybrid variant) is with AtSPL1 an AtMTP1 interaction candidate, which plays putatively a role in Zn,Cu homoestasis. The c” subunit of the vacuolar H+-ATPase AtVHA was found as likely AtMTP3-interaction candidate, as well as AtNPSN13, an protein that plays putatively a role in fusion of vesicles with target-membranes. Another method to identify new metal homeostasis genes is the comparative elemental analysis of natural and mutagenized plant populations. Prerequisite for this approach is the fast and accurate analysis of the elemental composition of plants. An established method for elemental analysis is Inductively Coupled Plasma Optical Emission Spectrometry (ICP OES). The limiting factor for high thoughput is the requirement for laborious wet digest of plant samples before analysis. An alternative mean of sample delivery to the ICP OES is electrothermal vaporization (ETV). For faster, less laborious analysis of plant material, a method based on the established coupling of ETV with ICP OES was developed, which is optimized for plant material and automated as far as possible.

Venezuelan equine encephalitis virus (VEEV) is an alphavirus that causes disease in humans and equines eliciting both an agricultural and public health threat. In humans, the disease typically presents as a febrile illness with common signs of fever and malaise. Four to fourteen percent of Venezuelan equine encephalitis (VEE) cases are associated with severe neurological complications due to encephalitis caused by VEEV's propensity to infect the brain. Public health concerns are exacerbated by VEEV's aerosolization capabilities, low infectious dose and affordability to mass produce. These qualities drove interest in the pathogen as a bioweapon by the US and the former Soviet Union during the cold war. As a precautionary response to VEEV's notoriety as a biothreat, the National Institute of Allergies and Infectious Diseases has classified VEEV as a category B priority pathogen, and the Human Health Services and United States Department of Agriculture list live virulent strains of VEEV as a select agent and require the pathogen to be manipulated in highly regulated biosafety level 3 (BSL3) facilities. There are currently no FDA approved vaccines or antivirals to target VEEV or other closely related alphaviruses associated with clinical disease in humans. The research performed in this dissertation aimed to elucidate new antiviral targets and treatments to help bridge gaps in current understanding of alphaviruses. The current market lacks available antibodies for E1 specific isolation. In response, a recombinant VEEV TC-83 was produced with a V5 tag at the C-terminal of the E1 sequence to enable VEEV E1 detection. Sequencing was used to verify V5 insertion in the plasmid and immunoprecipitation was used to verify V5 insertion within the E1 glycoprotein. Replication kinetics experiments verified the virus replicated similarly to the parental VEEV TC-83 strain, while passaging experiments verified the tag was highly stable for up to 10 passages. This research produced a cost-effective and highly efficient means to probe and isolate the E1 glycoprotein without modifying the viability of the virus. Knowledge of host protein interactions with VEEV E1 glycoprotein has been limited, with most E1 research focusing on its fusion capabilities. Utilizing 293-T cells infected with E1-V5 TC-83, co-immunoprecipitation was performed to isolate E1 and associated interactors. A total of 486 host and 5 viral protein interactors of E1 were discovered after normalization to the negative control. The top peptide spectrum matches (PSMs) revealed a number of chaperone proteins and ubiquitin proteins as top interactors of VEEV E1. These results effectively revealed a number of previously unknown alphavirus interactions that can be targeted by antivirals and explored further for implications in viral replication. LC-MS/MS results showed that protein disulfide isomerase family A member 6 (PDIA6) interacted with E1. High PSMs, presence in all 3 replicates, similar cellular localization to E1 and known associations between other viruses and protein disulfide isomerase (PDI) family members made this protein an optimum target for further analysis. Co-immunoprecipitation and co-localization experiments were used to validate the LC-MS/MS results. Involvement of PDIs in VEEV replication were explored utilizing two known PDI inhibitors, LOC14 and Nitazoxanide. LOC14, a non-FDA approved broad-spectrum PDI inhibitor, showed broad-spectrum alphavirus antiviral potential, decreasing titers of VEEV TC-83, VEEV Trinidad Donkey strain, eastern equine encephalitis virus (EEEV), chikungunya virus (CHIKV) and Sindbis (SINV) virus in a dose dependent manner. Nitazoxanide, an FDA approved drug known to inhibit PDIA3, was shown to have minimal toxicity and effectively reduced VEEV TC-83 and EEEV titers at concentrations with 100% cell viability. Time of addition assays, E1 expression time course studies, and early event assays showed PDI inhibition with these drugs effects early viral production events. RNA quantification, confocal microscopy and biotin switch assay experiments show that the drugs also prevented proper folding of the E1 glycoprotein and decreased expression of E1 on the peripheral membrane. With no current treatments for alphaviruses, these data provide an effective broad-spectrum target that affects viral replication at multiple stages in-vitro. Nitazoxanide also presents as a promising, non-toxic drug that could be repurposed to combat a number of clinically relevant alphaviruses. Valosin containing protein (VCP) was also shown to interact with the E1 glycoprotein. Exploration of VCP's interaction with alphavirus E1 has never been explored, yet it was previously shown to be involved in alphavirus replication. Co-localization and co-immunoprecipitation experiments were performed validating the interaction between VCP and E1. siRNA knockdown of VCP in 293-T cells and U87-MG cells showed a significant reduction in VEEV TC-83 titers. The allosteric VCP inhibitor, NMS-873, also reduced VEEV TC-83 titers, but was shown to be less effective against CHIKV, SINV and EEEV, suggesting the NMS-873 mechanism is more selective for VEEV. Mechanism experiments showed that reduction of VCP with NMS-873 inhibits early events of VEEV replication. These results elucidate VCP's association with E1 and show that VCP can be targeted to decrease VEEV viral replication. / Doctor of Philosophy / Venezuelan equine encephalitis virus (VEEV) causes disease in humans, as well as horses, donkeys and other closely related animals. In humans, the virus causes a flu-like disease and sometimes swelling of the brain. This can be associated with symptoms such as light sensitivity, confusion and sometimes coma. Prior to the Cold War, VEEV was researched by the US and previous Soviet Union's militaries in hopes to deploy the virus as a bioweapon. Current treaties prevent active production of such weapons, yet allows for defensive research to continue in preparation for a worst-case scenario. Currently no FDA approved medications or vaccines exist to combat the virus further exacerbating concerns. In order to protect laboratorians and prevent unintentional or intentional introduction of the virus into the community, the virus is only manipulated in highly secure facilities with barriers that separate the virus from personnel and the outside environment. A component of the virus called E1, allows for the virus to be released from a structure, called an endosome, that transports the virus into the cell. Currently, E1 is mostly known for this function, yet our research found that E1 interacts with 486 protein components of the host cell, suggesting a more elaborate role of E1 than previously understood. This list of interactors provides numerous new targets for potential medications to combat VEEV and other closely related viruses. Discovered E1 interactors, protein disulfide isomerase family A member 6 (PDIA6) and valosin containing protein (VCP), were validated through extensive experimentation and their function in viral replication was further explored. Protein disulfide isomerases (PDI), such as PDIA6, play an important role in folding proteins, which are cellular components made of organic building blocks called amino acids. PDIs do so by creating organic pillars, called disulfide bonds, between two cysteine amino acid residues. These disulfide bonds contribute to the 3D shape of the proteins they fold which are essential for the protein's function. E1 of VEEV has a total of eight disulfide bonds within its structure, highlighting that disulfide bonds are likely essential for the protein's structure, and therefore, function. We verified that E1 could not properly fold without PDI function by using two compounds that prevented PDI from forming or breaking disulfide bonds, specifically LOC14 and FDA approved drug nitazoxanide. Cells treated with one of either compound before and after infection with VEEV, were found to produce E1 protein with significantly less disulfide bonds therefore producing less viable virus. Further experiments also showed that the compounds also affected early stages in the virus production cycle. These two mechanisms explain the significant reduction in production of VEEV and related viruses when PDI is inhibited. These results provide a new VEEV drug target, PDIs, as well as two compounds that can potentially be used to combat VEEV and other related viruses that have no current treatment options. Another host interactor, VCP, functions throughout the cell and is known for unfolding of numerous substrates, including proteins. It is involved in numerous cellular functions thus making this interactor a promising target for drug treatment. Cells with reduced VCP function were shown to produce less progeny VEEV. Cells treated with NMS-873, a compound that reduces VCP function was also shown to reduce VEEV production. NMS-863 inhibition of VCP was shown to effect early events in VEEV replication. These results further emphasize the E1 interactors discovered are invaluable novel targets for VEEV drug treatment.

Les virus ont besoin d’interagir avec des facteurs cellulaires pour se répliquer et se propager dans les cellules d’hôtes. Une étude de l'interactome des protéines du virus d'hépatite C (VHC) par Germain et al. (2014) a permis d'élucider de nouvelles interactions virus-hôte. L'étude a également démontré que la majorité des facteurs de l'hôte n'avaient pas d'effet sur la réplication du virus. Ces travaux suggèrent que la majorité des protéines ont un rôle dans d'autres processus cellulaires tel que la réponse innée antivirale et ciblées pas le virus dans des mécanismes d'évasion immune. Pour tester cette hypothèse, 132 interactant virus-hôtes ont été sélectionnés et évalués par silençage génique dans un criblage d'ARNi sur la production interferon-beta (IFNB1). Nous avons ainsi observé que les réductions de l'expression de 53 interactants virus-hôte modulent la réponse antivirale innée. Une étude dans les termes de gène d'ontologie (GO) démontre un enrichissement de ces protéines au transport nucléocytoplasmique et au complexe du pore nucléaire. De plus, les gènes associés avec ces termes (CSE1L, KPNB1, RAN, TNPO1 et XPO1) ont été caractérisé comme des interactant de la protéine NS3/4A par Germain et al. (2014), et comme des régulateurs positives de la réponse innée antivirale. Comme le VHC se réplique dans le cytoplasme, nous proposons que ces interactions à des protéines associées avec le noyau confèrent un avantage de réplication et bénéficient au virus en interférant avec des processus cellulaire tel que la réponse innée. Cette réponse innée antivirale requiert la translocation nucléaire des facteurs transcriptionnelles IRF3 et NF-κB p65 pour la production des IFNs de type I. Un essai de microscopie a été développé afin d'évaluer l’effet du silençage de 60 gènes exprimant des protéines associés au complexe du pore nucléaire et au transport nucléocytoplasmique sur la translocation d’IRF3 et NF-κB p65 par un criblage ARNi lors d’une cinétique d'infection virale. En conclusion, l’étude démontre qu’il y a plusieurs protéines qui sont impliqués dans le transport de ces facteurs transcriptionnelles pendant une infection virale et peut affecter la production IFNB1 à différents niveaux de la réponse d'immunité antivirale. L'étude aussi suggère que l'effet de ces facteurs de transport sur la réponse innée est peut être un mécanisme d'évasion par des virus comme VHC. / Viruses interact with cellular factors in order to successfully replicate and propagate in host cells. Germain et al. (2014) performed a proteomics analysis to elucidate viral-host interactors of hepatitis C virus (HCV). They found that the majority of host factors did not have an effect on viral replication, suggesting that these host proteins may be beneficial to the virus by affecting other cellular processes such as evading the innate antiviral immunity. To test that hypothesis, 132 virus-host interactors were selected and silenced by RNAi for their effect on inteferon-beta (IFNB1) production as a readout of the innate antiviral response. 53 were found to modulate the response with enrichment in the gene ontology (GO) terms related to nucleocytoplasmic transport and the nuclear pore complex. An interesting point is that the genes associated with these terms (CSE1L, KPNB1, RAN, TNPO1, and XPO1) were previously elucidated as HCV NS3/4A interactors by Germain et al. (2014), as well as positive regulators of the innate antiviral response. Although it is surprising that a cytoplasmic-replicating virus like HCV would interact with proteins associated with the nucleus, we proposed that viruses interact with these proteins for their benefit to interfere with the innate immune response. The innate antiviral response requires the nuclear translocation of IRF3 and NF-κB p65 for the production of type I interferons. As it is unclear which transporters or nucleoporins are involved, 60 genes associated with the nuclear pore complex and nucleocytoplasmic transport were studied for their effect on the nuclear translocation of IRF3 and NF-κB p65 via a microscopy-based RNAi screen during a 10-hour viral infection time course. Overall, the study revealed that many of these proteins are involved in the trafficking of these transcription factors during a viral infection, and can affect the production of IFNB1 at different levels of the innate antiviral response. The study also suggests that the effect of these transport factors on the immune response may be an evasion mechanism for viruses such as HCV.